BioCentury
ARTICLE | Targets & Mechanisms

ASIRTaining a Parkinson's disease target

September 20, 2012 7:00 AM UTC

A Tufts University team has compelling evidence that reducing sirtuin 2

activity could be beneficial in Parkinson's disease.1 The findings argue for developing brain-penetrating sirtuin 2 inhibitors...